ATEN vs NVDA

The Advanced Deterministic Scorecard reveals a mixed financial profile for ATEN, with a Piotroski F-Score of 4/9 indicating borderline financial health and no available Altman Z-Score to assess bankruptcy risk. Despite solid profitability metrics—such as a 79.66% gross margin, 23.88% ROE, and consistent earnings surprises—the stock trades at a premium valuation (P/E 25.19 vs. sector avg 87.63) while exhibiting weak earnings growth (YoY -0.30%) and bearish insider activity. The current price of $17.38 is significantly above both the Graham Number ($6.68) and intrinsic value estimate ($4.83), suggesting overvaluation unless growth accelerates. Technical trend is bearish, and recent price performance has underperformed over the past year (-9.5%), offsetting strong long-term earnings execution and sector-relative resilience.

NVDA exhibits strong financial health with a Piotroski F-Score of 7/9, indicating robust operational efficiency and solvency. While the current price of $182.08 is significantly above the Graham Number ($26.71) and the growth-based intrinsic value ($144.55), the stock is fundamentally undervalued relative to its growth, as evidenced by a PEG ratio of 0.72 and a highly attractive Forward P/E of 16.38. The company's elite profitability margins (55.6% profit margin) and minimal debt (0.07 D/E) provide a massive cushion for volatility. Despite bearish insider sentiment and short-term technical weakness, the long-term growth trajectory remains exceptionally strong.